<?xml version="1.0" encoding="UTF-8"?>
<table id="PMC6835697/table_6" xmlns="http://www.w3.org/1999/xhtml">
 <caption>
  <label>Table 6</label>
  <p>Toxicity studies of GRFT in various cell and animal models.</p>
 </caption>
 <thead>
  <tr>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" id="0-0-.">Models Used</th>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" id="0-1-.">Dose Tested</th>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" id="0-2-.">Effects of GRFT</th>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" id="0-3-.">Ref.</th>
  </tr>
 </thead>
 <tbody>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Human cervical explants and rabbits</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Up to 2 μM</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No effect on the production of proinflammatory cytokines and chemokines. 
    <br/>No vaginal irritation in rabbits. 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[ 
    <a rid="B45-marinedrugs-17-00567" ref-type="bibr">45</a>] 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Human cervical epithelial cells, cervicovaginal cells, and PBMCs</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Up to 84 μM</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Minimal changes in secretion of inflammatory cytokines and chemokines 
    <br/>No measurable effect on cell viability and T-cell activation markers. 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[ 
    <a rid="B43-marinedrugs-17-00567" ref-type="bibr">43</a>] 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Guinea pig 
    <br/>BALB/c mice 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Single 50 mg/kg and 10 daily subcutaneous injections of 10 mg/kg </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Minimal overall toxicity. 
    <br/>Well tolerated. 
    <br/>Increase in spleen and liver mass. 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[ 
    <a rid="B41-marinedrugs-17-00567" ref-type="bibr">41</a>] 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mouse PBMC and BALB/c mice with parenteral administration</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Up to 4 μM in vitro, subcutaneously with a single dose of 10 mg/kg, fourteen daily doses of 10 mg/kg, 2 mg/kg subcutaneous, intravaginal, and intraperitoneal administration</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No mitogenic properties in vitro. 
    <br/>No effect on cell surface activation markers or animal fitness. 
    <br/>No major organ toxicity with reversible splenomegaly. 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[ 
    <a rid="B44-marinedrugs-17-00567" ref-type="bibr">44</a>] 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rhesus macaques</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Intravaginal 0.1% gels</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No change in rental proteome or microbiome</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[ 
    <a rid="B42-marinedrugs-17-00567" ref-type="bibr">42</a>] 
   </td>
  </tr>
 </tbody>
</table>
